tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
TBPH is currently covered by 6 analysts with an average price target of $16.87. This is a potential upside of $7.18 (74.1%) from yesterday's end of day stock price of $9.69.
Theravance Biopharma's activity chart (see below) currently has 68 price targets and 46 ratings on display. The stock rating distribution of TBPH is 27.27% HOLD, 63.64% BUY and 9.09% SELL.
Analysts average stock forecasts to be materialized ratio is 35.21% with an average time for these price targets to be met of 99.25 days.
Highest price target for TBPH is $20, Lowest price target is $10, average price target is $16.87.
Most recent stock forecast was given by MARC FRAHM from TD COWEN on 08-Nov-2023. First documented stock forecast 03-Feb-2015.
Currently out of the existing stock ratings of TBPH, 3 are a HOLD (27.27%), 7 are a BUY (63.64%), 1 are a SELL (9.09%).
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
10
$0.53 (5.60%)
9
5 months 11 days ago
3/5 (60%)
$-0.25 (-2.44%)
96
Buy
20
$10.53 (111.19%)
20
8 months 11 days ago
3/10 (30%)
$10.26 (105.34%)
35
Buy
14
$4.53 (47.84%)
12
1 years 5 months 2 days ago
0/2 (0%)
$2.66 (23.46%)
Sell
10
$0.53 (5.60%)
10
1 years 8 months 25 days ago
2/8 (25%)
$0.76 (8.23%)
70
Buy
12
$2.53 (26.72%)
10
1 years 10 months 27 days ago
3/8 (37.5%)
$2.6 (27.66%)
85
What is TBPH (Theravance Biopharma) average time for price targets to be met?
Which analyst has the current highest performing score on TBPH (Theravance Biopharma) with a proven track record?
Which analyst has the most public recommendations on TBPH (Theravance Biopharma)?
Which analyst is the currently most bullish on TBPH (Theravance Biopharma)?
Which analyst is the currently most reserved on TBPH (Theravance Biopharma)?
